These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. [Human recombinant erythropoietin in treatment of uremic anemia in children with continual ambulatory peritoneal dialysis]. Litwin M; Boguszewska-Baczkowska A; Jelonek A Pol Tyg Lek; 1994 Feb 7-14; 49(6-7):135-6. PubMed ID: 8090665 [TBL] [Abstract][Full Text] [Related]
4. Long-term effects of recombinant human erythropoietin therapy on growth hormone secretion in uremic patients undergoing peritoneal dialysis. Díez JJ; Iglesias P; Sastre J; Aguilera A; Bajo MA; Méndez J; Gómez Pan A; Selgas R Metabolism; 1999 Feb; 48(2):210-6. PubMed ID: 10024084 [TBL] [Abstract][Full Text] [Related]
5. Measurement of serum levels of macrophage colony-stimulating factor (M-CSF) in patients with uremia. Kawano Y; Takaue Y; Motoyoshi K; Minakuchi J; Kawashima S; Saito S; Hirao A; Sato J; Shimizu T; Kuroda Y Exp Hematol; 1993 Feb; 21(2):220-3. PubMed ID: 8425560 [TBL] [Abstract][Full Text] [Related]
6. The effect of recombinant human erythropoietin (r-Hu EPO) administration on the blood chemistries and composition in uremic rats. Kozioł M; Ksiazek P; Feldo M; Spasiewicz D; Michalak J; Kleinrok Z Ann Univ Mariae Curie Sklodowska Med; 1994; 48 Suppl 3():61-6. PubMed ID: 8192533 [TBL] [Abstract][Full Text] [Related]
7. Possible relation between restless legs and anaemia in renal dialysis patients. Roger SD; Harris DC; Stewart JH Lancet; 1991 Jun; 337(8756):1551. PubMed ID: 1675404 [No Abstract] [Full Text] [Related]
9. Influence of recombinant human erythropoietin treatment on cortisol responses to insulin-induced hypoglycemia in CAPD patients. Díez JJ; Iglesias P; Sastre J; Gómez-Pan A; Selgas R; Romero JR; Méndez J Adv Perit Dial; 1993; 9():336-41. PubMed ID: 8105958 [TBL] [Abstract][Full Text] [Related]
10. Human erythropoietin improves the blood platelet phospholipid composition in chronically hemodialyzed patients. Krawczyk W; Dmoszyńska A; Marczewski K; Ledwozyw A Exp Nephrol; 1995; 3(4):265-6. PubMed ID: 8590040 [TBL] [Abstract][Full Text] [Related]
11. The adverse effects of recombinant human erythropoietin therapy. Wong KC; Li PK; Lui SF; Nicholls MG; Lai KN Adverse Drug React Acute Poisoning Rev; 1990; 9(4):183-206. PubMed ID: 2088088 [No Abstract] [Full Text] [Related]
12. Management of iron deficiency in renal anemia: guidelines for the optimal therapeutic approach in erythropoietin-treated patients. Drüeke TB; Bárány P; Cazzola M; Eschbach JW; Grützmacher P; Kaltwasser JP; Macdougall IC; Pippard MJ; Shaldon S; van Wyck D Clin Nephrol; 1997 Jul; 48(1):1-8. PubMed ID: 9247771 [TBL] [Abstract][Full Text] [Related]
13. Importance of iron status monitoring during erythropoietin treatment in uremic predialysis patients. Rutkowski B; Debska-Slizień A; Biedunkiewicz B; Bułło B Ann Univ Mariae Curie Sklodowska Med; 1994; 48 Suppl 3():17-21. PubMed ID: 8192528 [TBL] [Abstract][Full Text] [Related]
14. Changes in partition of extracellular fluid volumes in anemic dialyzed uremic patients after partial correction of the anemia with recombinant human erythropoietin treatment. Cannella G; Guerra UP; Sandrini M; Gaggiotti M; Traverso GB; Rolla D; Marsano L; Mulas D Clin Nephrol; 1993 Sep; 40(3):164-7. PubMed ID: 8403572 [TBL] [Abstract][Full Text] [Related]
15. Influence of long-term erythropoietin treatment on plasma levels of calcium-phosphate related hormones in haemodialyzed uraemic patients. Kokot F; Wiecek A; Marcinkowski W; Schmidt-Gayk H; Rudka R; Trembecki J Ann Univ Mariae Curie Sklodowska Med; 1994; 48 Suppl 3():9-16. PubMed ID: 8192535 [TBL] [Abstract][Full Text] [Related]